Roundtable Discussion: Securing Funding for Ophthalmic Gene Therapies: Understanding Investor Priorities & Navigating the Investment Landscape in Ophthalmic Innovation

Time: 4:15 pm
day: Day One 11th

Details:

  • Exploring the criteria that investors consider when evaluating gene therapy projects, including scientific innovation, market potential, and feasibility
  • Discussing the importance of demonstrating a clear path to clinical translation and commercialization to attract investment
  • Discussing the impact of regulatory approvals, clinical trial outcomes, and market dynamics on investor sentiment and funding decisions
  • Identifying emerging opportunities and challenges in securing investment for ophthalmic gene therapy projects and strategies to address them